发明名称 Methods of use comprising deuterated pyrazino[2,1-a]isoquinolines
摘要 This invention in one embodiment is directed to a compound of Formula Ia;; where the designation (R) indicates that the designated carbon has the (R) stereochemistry; and wherein Z1 is hydrogen or fluorine; Z2 is hydrogen, deuterium, or fluorine; Z3 is deuterium; Z4 is fluorine; m is an integer from 0 to 10; n is an integer from 0 to 2; provided that: the sum of m+n does not exceed 10; and when both Z1 and Z2 are hydrogen, the sum of m+n is greater than 0, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an antihelminthic agent, such as praziquantel.
申请公布号 US9206179(B2) 申请公布日期 2015.12.08
申请号 US201414518254 申请日期 2014.10.20
申请人 Concert Pharmaceuticals, Inc. 发明人 Liu Julie F.;Harbeson Scott L.;Tung Roger D.
分类号 C07D241/38;C07D471/04;C07B59/00;A61K31/4184;A61K31/4985 主分类号 C07D241/38
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Davis Steven G.;Dertz Emily
主权项 1. A method of disrupting cell permeability to calcium ions in a parasitic cell, comprising contacting said cell with a compound of Formula Ia:or a pharmaceutically acceptable salt thereof, wherein: Z1 is hydrogen or fluorine; Z2 is hydrogen, deuterium, or fluorine; Z3 is deuterium; Z4 is fluorine; m is 2, 4, 6, 8 or 10; and n is 0 or 2;provided that: the sum of m and n does not exceed 10.
地址 Lexington MA US
您可能感兴趣的专利